Austria: medical and donor requirements for assisted reproduction—and the surrogacy limit
Legal starting point
Austria separates lawful medically assisted reproduction for a person who will herself become pregnant from surrogacy, where another woman carries a pregnancy for intended parents. Donor sperm and donor eggs are permitted in defined circumstances under the Fortpflanzungsmedizingesetz (FMedG), but they are not an exception allowing an Austrian clinic to arrange a surrogate pregnancy. The practical first question is therefore not “Can we find a donor?” but “Who will carry the pregnancy, and under which legal indication?” This guide addresses clinical and gamete rules under Austrian law as of 20 October 2026, not foreign treatment or a guarantee of clinical acceptance.
The Austrian government expressly states that surrogacy is prohibited. The legal architecture permits treatment in specified relationships and regulates whose cells may be used; it does not create a gestational-carrier route for a third woman. The Ministry of Foreign Affairs also describes the woman who gives birth as the mother under Austrian law. Do not treat a donor-egg pathway, a consent form, or a private carrier agreement as proof that surrogacy is permitted. Cross-border recognition and birth registration are different questions and must be assessed separately.
Which treatments can be considered?
Statutory eligibility and medical indication
Section 2(1) FMedG confines assisted reproduction to marriage, registered partnership or a cohabiting relationship. It is not a general service available to any single applicant. Whether particular people qualify under this relationship rule is a separate assessment; nationality alone does not answer it. For a proposed treatment, identify both participants and the person who would be pregnant before asking for a clinic quotation. A clinic cannot replace the statutory relationship or medical conditions with its own more permissive policy.
Section 2(2) provides alternative statutory grounds: other possible and reasonable treatments for pregnancy through intercourse have failed or are hopeless; intercourse presents a lasting serious risk of transmitting a grave infectious disease; treatment aims to establish a pregnancy in one of two women in a qualifying partnership; or treatment is necessary for legally permitted preimplantation diagnosis. These are alternatives, not a demand that every patient prove infertility. Where several suitable methods exist, section 2(3) directs the clinician initially to use the lower-risk approach that produces fewer viable cells, considering the child’s welfare.
When can donor sperm or donor eggs be used?
The default under section 3 is use of the partners’ own sperm and eggs. Donor sperm is an exception if the male partner’s sperm cannot reproduce, or where treatment concerns two women in a qualifying registered partnership or cohabitation. The exception is not an unrestricted market in gametes. Donor sperm may also be used with in-vitro techniques when the statutory ground is met; it is not limited to insemination. The clinic must record why the applicable exception is available.
Donor eggs are possible only where the eggs of the woman who is to become pregnant are incapable of reproduction and she has not yet reached 45 at the start of treatment (section 3(3)). This age threshold concerns the recipient, not the person supplying the eggs. The treatment must seek pregnancy in that recipient herself; donating eggs to support a separate carrier for intended parents does not bypass the surrogacy prohibition. Ask the treating specialist to document both the ovarian indication and the date treatment starts.
Under sections 2b and 13, donors of sperm or eggs must be at least 18; eggs intended for another person may be collected only before the egg donor’s 30th birthday. These are collection/use rules, not a general statutory age ceiling for all IVF patients. Both donors and recipients may face medical suitability assessments set by legislation and professional practice. Check the exact dates of collection, treatment and consent rather than relying on an informal statement that someone is “young enough.”
The matrix below distinguishes statutory requirements from additional checks made by a clinic. It is a checklist, not a decision that a particular applicant qualifies; other legal conditions and medical assessments still apply. A donor’s willingness or an advertisement for donor treatment creates neither a right to treatment nor permission to use a surrogate.
Practical legal checklist
| Issue | Statutory rule | Practical check |
|---|---|---|
| Carrier for intended parents | Surrogacy prohibited | No Austrian donor exception legalises the carrier arrangement. |
| Donor sperm | Specific infertility or qualifying two-woman partnership | Confirm section 3(2) basis and approved donor pathway. |
| Donor eggs | Recipient’s eggs incapable; recipient under 45 at treatment start | The recipient must be the woman becoming pregnant. |
| Egg donor | At least 18 and under 30 when eggs are collected | Check date of birth against retrieval date. |
| Donor-gamete clinic | Specifically authorised facility with mandatory screening | Ask for authorisation and protocol, not just advertising. |
| Consent and counselling | Personal donor consent; partner consent, notarial form when required | Schedule physician and notary before the cycle. |
Clinical safety, consent and recordkeeping
Donor-based assisted reproduction must take place in a hospital or clinic specifically authorised for that activity; a doctor must hold the prescribed professional qualification. Under sections 11–12, the facility must examine both the donor and the donated material to assess reproductive suitability and health risks for the woman and prospective child. The legal requirement is screening and proper authorisation; the specific laboratory panel, thresholds, repeat tests and appointment sequence should be confirmed in writing with the licensed provider.
Written donor consent is compulsory, must be given personally and with decision-making capacity, and covers use of the gametes and statutory donor-information disclosures (section 13). Donors provide gametes for assisted reproduction through one hospital or clinic only; section 14 limits use of a donor’s gametes to a maximum of three marriages, registered partnerships or cohabiting relationships. These limits are operational controls, not guarantees about pregnancy outcomes. Ask which institution holds the donation records and how it checks prior use. Section 14(3) additionally forbids using sperm from different men or eggs from different women in one assisted-reproduction procedure; ask the clinic how it verifies the provenance of the gametes.
The treating partners must also consent. Under section 8, a notarial deed is required for cohabiting partners or whenever third-party sperm or eggs are used. Section 7 requires notarial counselling on the legal consequences for registered partners and cohabitants, and for married couples when third-party gametes are involved. Consent is personal and requires capacity. The document must identify the participants, express consent to treatment and, where relevant, donation, and specify the authorised treatment period. A clinic signature form does not automatically replace the statutory notarial form.
The physician must provide understandable medical explanation at least 14 days before treatment, including indications, alternatives, prospects, risks, possible effects on the woman and child, medicines, complications, follow-up and expected costs (section 7). The physician must propose psychological or psychotherapeutic support and identify opportunities for independent advice. This counselling is a statutory obligation; the exact appointment format and additional clinic questionnaires are operational details. In donor cases, legal and psychological questions about a child’s future access to origin information deserve discussion before consent.
Either treating partner may revoke consent to the physician until sperm, eggs or viable cells are introduced into the woman’s body; the revocation has no prescribed form and the physician must document it. Partners’ consent must not be older than two years at introduction (section 8). A donor may withdraw permission for further use by notifying the clinic (section 13); the clinic should determine and document what material remains unused. Do not assume a consent signed for an earlier cycle can simply be reused after a change in partner or treatment plan.
Donations cannot be sold. Section 16 prohibits a paid transaction for sperm or eggs, and reimbursement above proven out-of-pocket expenditure linked to the donation’s medical treatment is treated as payment. It also prohibits specified mediation and advertising of cells or willing donors. This rule must not be confused with the separate price charged by a clinic for lawful medical services. Obtain an itemised explanation of any donor-related sum rather than accepting an undefined “compensation” or recruitment fee.
Donor identity and testing data must be recorded and retained. Sections 15 and 18 prescribe 30-year recordkeeping, with transfer to the provincial governor for permanent retention at the specified endpoint. Under section 20, a child conceived with donated gametes may request access to the donor records after turning 14. Earlier medically justified disclosure to the child’s legal representative is possible in exceptional cases; competent authorities also have restricted access. “Anonymous donor” should therefore not be understood as a promise of lifelong secrecy from the child. For access, contact the treating hospital or clinic, or the competent provincial governor if it has closed. Where a child was conceived with donor sperm before 24 February 2015, a legal representative seeking access also needs guardianship-court approval; this additional requirement does not apply to conceptions from that date.
Additional limits and practical examples
Embryo genetic testing is not an optional routine service. Section 2a limits preimplantation genetic diagnosis to prescribed situations, including specified repeated failed transfers, repeated medically documented miscarriage or stillbirth, or serious parental genetic risk; it also narrows the permissible testing to what is necessary. Sex selection is allowed only in the defined sex-linked hereditary-disease situation. Section 9 otherwise restricts interventions into the germline. A clinic’s genetic-testing package is not evidence that any requested embryo selection is legal. Obtain an indication linked to section 2a before commissioning tests.
Consider two scenarios. A woman aged 44 who will herself carry a pregnancy and has medically documented non-functioning eggs may qualify for donor-egg treatment if the partnership, clinical, consent and donor conditions are also met; the result is not automatic approval. By contrast, partners who have healthy embryos but plan to transfer them to an unrelated woman acting as their carrier cannot turn that plan into lawful Austrian surrogacy by labelling the carrier an “egg recipient.” The identity of the woman carrying the child changes the legal answer.
Documents to prepare and decisions to take
Before requesting treatment, collect identity and relationship evidence, relevant fertility histories, specialist reports supporting the section 2 or section 3 ground, test results already available, and a concise statement of who will carry the pregnancy. If donor gametes are proposed, also confirm donor age and the authorised clinic’s screening process, then arrange statutory counselling and the appropriate notarial deed or other consent documents. This is a working preparation checklist, not a claim that the law prescribes a single standard application pack; ask the clinic which originals, translations and fresh tests it actually requires.
Send the proposed Austrian provider five concrete questions: which FMedG ground covers the treatment; who is the patient carrying the pregnancy; which donor exception applies; which screening, medical explanations and consents will be documented; and which conditions are legal requirements rather than clinic policy. Request its approval status for donor treatment and an itemised written protocol before any deposit. If the provider refuses treatment, ask for the specific clinical or legal reason and whether supplementary evidence or an independent second opinion could address it. No general right to force a clinician to perform treatment follows from eligibility: section 6 protects a professional’s freedom not to participate.
Bottom line: Austrian law can permit regulated donor-assisted reproduction for a qualified patient who will carry her own pregnancy, subject to relationship, medical, donor, clinic, counselling and consent rules. It does not permit surrogacy through a different woman. Establish the carrier and legal indication first, then verify age limits, donor screening, notarial formalities and clinic policies. Foreign arrangements, parentage and child documents require their own jurisdiction-specific review; none follows automatically from compliance with Austrian donor rules.
